| Authors: |
Abraham JE; Precision Breast Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, United Kingdom. ja344@cam.ac.uk.; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, United Kingdom. ja344@cam.ac.uk., O'Connor LO; AstraZeneca, Cambridge, United Kingdom., Grybowicz L; Cambridge Cancer Trials Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Alba KP; Precision Breast Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, United Kingdom., Dayimu A; Cambridge Clinical Trials Centre, Cancer Theme, University of Cambridge, Cambridge, United Kingdom., Demiris N; Department of Statistics, Athens University of Economics and Business, Athens, Greece., Harvey C; Cambridge Cancer Trials Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Drewett LM; Royal Devon University Healthcare NHS Foundation Trust, Exeter, United Kingdom., Lucey R; Precision Breast Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, United Kingdom., Fulton A; Precision Breast Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, United Kingdom., Roberts AN; Cambridge Cancer Trials Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Worley JR; Precision Breast Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, United Kingdom., Chhabra MA; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Qian W; Cambridge Clinical Trials Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Brown J; AstraZeneca, Cambridge, United Kingdom., Hardy R; Cambridge Clinical Trials Centre, Cancer Theme, University of Cambridge, Cambridge, United Kingdom., Vallier AL; Cambridge Cancer Trials Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Chan S; The City Hospital, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.; Nottingham Breast Cancer Research Centre, University of Nottingham, Nottingham, United Kingdom., Cidon MEU; Royal Bournemouth General Hospital, University Hospitals Dorset NHS Foundation Trust, Bournemouth, United Kingdom., Sherwin E; Ipswich Hospital, East Suffolk and North Essex NHS Foundation Trust, Ipswich, United Kingdom., Chakrabarti A; University Hospitals Dorset NHS Foundation Trust, Poole, United Kingdom., Sadler C; Apconix Ltd, Alderley Edge, Cheshire, United Kingdom., Barnes J; AstraZeneca, Cambridge, United Kingdom., Persic M; University Hospital of Derby and Burton, Derby, United Kingdom., Smith S; Bedford Hospital, Bedfordshire Hospitals NHS Foundation Trust, Bedford, United Kingdom., Raj S; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.; Hampshire Hospitals NHS Foundation Trust, Hampshire, United Kingdom., Borley A; Velindre Cancer Centre, Cardiff, United Kingdom., Braybrooke JP; University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom., Staples E; Queens Hospital, Barking, Havering and Redbridge University Hospitals NHS Trust, Romford, United Kingdom., Scott LC; Beatson West Of Scotland Cancer Centre, Glasgow, Scotland, United Kingdom., Palmer CA; Hinchingbrooke Hospital, North West Anglia NHS Foundation Trust, Huntingdon, United Kingdom., Moody M; Macmillan Unit, West Suffolk Hospital NHS Foundation Trust, Bury St Edmunds, United Kingdom., Churn MJ; Worcestershire Acute Hospitals NHS Trust, Worcester, United Kingdom., Pilger D; AstraZeneca, Cambridge, United Kingdom., Zagnoli-Vieira G; AstraZeneca, Cambridge, United Kingdom., Wijnhoven PWG; AstraZeneca, Cambridge, United Kingdom., Mukesh MB; Colchester General Hospital, East Suffolk & North Essex NHS Trust, Colchester, United Kingdom., Roylance RR; University College London Hospitals NHS Foundation Trust, London, United Kingdom., Schouten PC; Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Levitt NC; Oxford University Hospital NHS Foundation Trust, Oxford, United Kingdom., McAdam K; Peterborough City Hospital, North West Anglia NHS Foundation Trust, Peterborough, United Kingdom., Armstrong AC; The Christie NHS Foundation Trust, Manchester, United Kingdom., Copson ER; Cancer Sciences Academic Unit, University of Southampton, Southampton, United Kingdom., McMurtry E; EMC2 Clinical Consultancy Ltd, Sale, United Kingdom., Galbraith S; AstraZeneca, Cambridge, United Kingdom., Tischkowitz M; Department of Genomic Medicine, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK., Provenzano E; Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., O'Connor MJ; AstraZeneca, Cambridge, United Kingdom., Earl HM; Department of Oncology, University of Cambridge, Cambridge, United Kingdom. |
